After three silver and two bronze medals at the previous four Olympic Games, Elana Meyers Taylor won her first gold medal at the 2026 Winter Olympics at age 41. She’s joining Breastcancer.org as an ambassador for the Ultimate Teammate campaign, helping people understand how to lower their breast cancer risk and take charge of their breast health.

Listen to the episode to hear Elana talk about:

Oligometastatic breast cancer is breast cancer that’s spread to parts of the body away from the breast, like the bones or liver, but there are only a few small cancer lesions at the metastatic site. Dr. Jennifer Plichta, of Duke University, was the corresponding author of a paper looking at treatments for oligometastatic breast cancer, including surgery to remove the primary tumor in the breast and removing the metastatic lesion with surgery or treating it with radiation. The study found that removing the primary breast tumor was associated with better survival.

Listen to the episode to hear Dr. Plichta explain:

At the Living Beyond Breast Cancer 2026 Conference on Metastatic Breast Cancer, five members of the Breastcancer.org metastatic virtual support groups shared what they’d tell someone who’s just been diagnosed with metastatic breast cancer. They talked to us about the importance of having hope allowing yourself to grieve, seeking out support, and knowing that you’re never alone.

At the 2026 American Society of Clinical Oncology Annual Meeting poster session, we asked four scientists to discuss their research.

Listen to the episode to hear:

Felicia Marie Knaul, PhD, is a global health researcher whose work focuses on strengthening health systems, advancing gender equity, and improving access to care for those who need it most. She’s also lived through a breast cancer diagnosis and treatment, and that experience informs her efforts to transform health systems around the world.

Listen to the episode to hear Dr. Knaul discuss:

Eleonora Teplinsky, MD, is the head of breast and gynecologic medical oncology and Valley-Mount Sinai Comprehensive Cancer Center in Paramus, New Jersey, as well as an ASCO breast cancer expert. She explained the most compelling research results on breast cancer presented at the 2026 American Society of Clinical Oncology Annual Meeting.

Listen to the episode to hear Dr. Teplinsky explain:

At the 2026 American Society of Clinical Oncology Annual Meeting, Dr. Jennifer Ligibel, director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living at the Dana-Farber Cancer Institute, presented early results from the Breast Cancer Weight Loss (BWEL) study. The findings showed that among women with early-stage breast cancer, losing weight led to better physical and mental health, and also helped ease fatigue.

Listen to the episode to hear Dr. Ligibel explain:

Results from the OPTIMA trial suggest that people with early-stage hormone receptor-positive, HER2-negative breast cancer that seems to have a high risk of recurrence based on clinical features — like a high number of positive lymph nodes — may be able to safely skip chemotherapy if they have a low Prosigna risk of recurrence score. The findings were presented at the 2026 American Society of Clinical Oncology Annual Meeting.

Iain MacPherson, professor of breast oncology at the University of Glasgow, was chief investigator of the study.

Listen to the episode to hear Dr. MacPherson explain:

At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Megan-Claire Chase, known as Warrior Megsie on social media, was one of the speakers at the ASCO Voices session. In her talk, she explained how her views on clinical trials shifted after she was diagnosed with breast cancer.

Listen to the episode to hear Megsie explain:

Dr. Michael Stubblefield is a cancer rehabilitation expert and Dr. Joseph Dayan is a plastic and reconstructive surgeon who has pioneered techniques to ease lymphedema with surgery. They’re both very interested in how the GLP-1 medicines, like Ozempic, Wegovey, Zepbound, Mounjaro, Victoza, and Trulicity — just to name a few — could be used to manage lymphedema.

Listen to the episode to hear Drs. Stubblefield and Dayan explain: